Mi Kwon Son

Mi Kwon Son

UNVERIFIED PROFILE

Are you Mi Kwon Son?   Register this Author

Register author
Mi Kwon Son

Mi Kwon Son

Publications by authors named "Mi Kwon Son"

Are you Mi Kwon Son?   Register this Author

28Publications

-Reads

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.

Oncotarget 2017 Dec 1;8(68):112893-112906. Epub 2017 Dec 1.

Department of Drug Development, College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
December 2017

Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer" [Cancer Lett. 396 (2017) 155-166].

Cancer Lett 2017 09 22;404:93. Epub 2017 Jun 22.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea. Electronic address:

View Article
September 2017

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.

Cancer Lett 2017 09 6;403:339-353. Epub 2017 Jul 6.

Department of Medicine, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon, 400-712, Republic of Korea. Electronic address:

View Article
September 2017

Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer.

Cancer Lett 2017 06 15;396:155-166. Epub 2017 Mar 15.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon, 400-712, Republic of Korea. Electronic address:

View Article
June 2017

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.

Oncotarget 2016 Nov;7(47):78029-78047

Department of Biomedical Sciences, College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
November 2016

Therapeutic effect of human clonal bone marrow-derived mesenchymal stem cells in severe acute pancreatitis.

Arch Pharm Res 2015 21;38(5):742-51. Epub 2014 Aug 21.

Department of Drug Development, Inha University School of Medicine, 7-241, 3-ga, Sinheung-dong, Jung-Gu, Incheon, 400-712, Korea.

View Article
February 2016

Aminoacyl-tRNA synthetase interacting multi-functional protein 1 attenuates liver fibrosis by inhibiting TGFβ signaling.

Int J Oncol 2016 Feb 18;48(2):747-55. Epub 2015 Dec 18.

Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, Gyunggido, Republic of Korea.

View Article
February 2016

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.

Int J Oncol 2015 Jul 11;47(1):253-61. Epub 2015 May 11.

Department of Biomedical Sciences, College of Medicine, Inha University, Incheon 400-712, Republic of Korea.

View Article
July 2015

Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells.

Cancer Lett 2014 Oct 10;353(1):68-77. Epub 2014 Jul 10.

Department of Drug Development, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea. Electronic address:

View Article
October 2014

Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.

Oncotarget 2014 Oct;5(19):9150-68

College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
October 2014

HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.

Int J Oncol 2014 Jul 9;45(1):311-21. Epub 2014 May 9.

College of Medicine, Inha University, Incheon 400-712, Republic of Korea.

View Article
July 2014

HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Cancer Lett 2014 Jun 18;348(1-2):50-60. Epub 2014 Mar 18.

College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea. Electronic address:

View Article
June 2014

HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis.

Sci Rep 2013 Dec 11;3:3470. Epub 2013 Dec 11.

1] Department of Medicine, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea [2].

View Article
December 2013

Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer.

Cancer Lett 2013 Sep 13;338(2):271-81. Epub 2013 Apr 13.

Department of Drug Development, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
September 2013

SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities.

Carcinogenesis 2013 Sep 13;34(9):2156-69. Epub 2013 May 13.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
September 2013

A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells.

Oncol Rep 2013 Aug 27;30(2):863-9. Epub 2013 May 27.

Department of Drug Development, College of Medicine, Inha University, Sinheung‑dong, Jung‑gu, Incheon 400-712, Republic of Korea.

View Article
August 2013

SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells.

Oncol Rep 2013 Aug 4;30(2):801-8. Epub 2013 Jun 4.

Department of Drug Development, College of Medicine, Inha University, Sinheung‑dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
August 2013

A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.

Int J Oncol 2013 Jun 16;42(6):2001-8. Epub 2013 Apr 16.

Department of Biomedical Sciences, College of Medicine, Inha University, Incheon 400-712, Republic of Korea.

View Article
June 2013

Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.

Cancer Lett 2013 May 20;331(2):250-61. Epub 2013 Jan 20.

College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
May 2013

A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway.

Cancer Lett 2013 Feb 17;329(1):59-67. Epub 2012 Oct 17.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon, Republic of Korea

View Article
February 2013

Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.

Cancer Lett 2013 Jan 15;328(1):176-87. Epub 2012 Aug 15.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
January 2013

Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis.

Mol Med Rep 2013 Jan 5;7(1):26-30. Epub 2012 Nov 5.

Department of Biomedical Sciences, College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
January 2013

SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.

Cancer Sci 2012 Nov 25;103(11):1929-37. Epub 2012 Sep 25.

Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea.

View Article
November 2012

Apoptotic and anti-angiogenic effects of Pulsatilla koreana extract on hepatocellular carcinoma.

Int J Oncol 2012 Feb 20;40(2):452-60. Epub 2011 Sep 20.

Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

View Article
February 2012